Page last updated: 2024-08-24

delphinidin and Animal Mammary Carcinoma

delphinidin has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bräse, S; Bulat, B; Cremers, N; Dimmler, A; Eschbach, V; Göppert, B; Jung, N; Marko, D; Plaumann, D; Quagliata, L; Rothley, M; Schmaus, A; Sleeman, JP; Teller, N; Thaler, S; Thiele, W; Vanderheiden, S	1

Other Studies

1 other study(ies) available for delphinidin and Animal Mammary Carcinoma

Article	Year
Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats. Carcinogenesis, 2013, Volume: 34, Issue:12 Topics: Animals; Anthocyanins; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chemoprevention; Endothelial Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Lymphangiogenesis; Lymphatic Metastasis; Mammary Neoplasms, Animal; Neovascularization, Pathologic; Phosphorylation; Rats; Rats, Wistar; Vascular Endothelial Growth Factor Receptor-2	2013

Article

Year

Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats.

Carcinogenesis, 2013, Volume: 34, Issue:12

Topics: Animals; Anthocyanins; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chemoprevention; Endothelial Cells; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Lymphangiogenesis; Lymphatic Metastasis; Mammary Neoplasms, Animal; Neovascularization, Pathologic; Phosphorylation; Rats; Rats, Wistar; Vascular Endothelial Growth Factor Receptor-2

2013